Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel

Phase 3 Completed 59 enrolled Ipsen

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether subjects with acromegaly (or their partners) are able to self administer Somatuline Autogel at home.

Timeline

Start: 2007-04
Primary completion: 2008-12
Completion: 2008-12

Publications

Results Salvatori R, Nachtigall LB, Cook DM, Bonert V, Molitch ME, Blethen S, Chang S; SALSA Study Group. Effectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naive patients with acromegaly. Pituitary. 2010 Jun;13(2):115-22. doi: 10.1007/s11102-009-0207-x.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lanreotide	Other / unclassified	60 mg	Subcutaneous
Subject	Lanreotide	Other / unclassified	90 mg	Subcutaneous
Subject	Lanreotide	Other / unclassified	120 mg	Subcutaneous

Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel

Summary

Timeline

Publications

Drugs

Indications